The generalisability of randomised clinical trials: An interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer. (October 2020) - De Boniface, J.; Ahlgren, J.; Andersson, Y.; Bergkvist, L.; Frisell, J.; Lundstedt, D.; Bagge, R.Olofsson; Rydén, L.; Sund, M.; ,